« Back
Integrating compound storage into automated laboratory workflows
Integrating compound storage into automated laboratory workflows
Submitted on 06 Mar 2014

James Craven, Simon Tullett
TTP Labtech
Poster Views: 1,672
View poster »
Poster Abstract
The demand for automated storage facilities for a wide range of compounds, small molecules, fragments and RNAi libraries and biologics is rapidly increasing as sample libraries expand across a range of industries and applications.

TTP Labtech’s comPOUND® offers robust storage for chemical and biological samples, which has been successfully employed for over a decade. comPOUND modules have been relied on by large pharmaceutical companies, academic research facilities and hospitals, as well as small biotech and contract research organisations who are committed to providing rapid throughput and delivery of high quality samples.

There has been considerable investment in automated storage facilities for compound and biological libraries, alongside automated instrumentation for liquid handling, HTS, HCS and analysis. Despite this, the process of sample transfer between such instrumentation still relies on manual effort. Often samples need to be transferred over considerable distances between storage rooms or even laboratories. On arrival, scientists need to prepare samples and place tubes or microplates into automated liquid handling platforms or assay instrumentation.

This poster discusses the benefits of comPOUND for automated sample storage and delivery. TTP Labtech’s pneumatic transport technology, lab2lab, enables integration of these stores with other instrumentation into managed, fully automated workflows - from sample storage to liquid handling, assay set-up, experimental analysis and QC. This allows the scientist to concentrate on research and data analysis.
Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

The MODEL-AD consortium preclinical testing pipeline: pharmacokinetics and pharmacodynamics of prophylactic treatment with levetiracetam on the 5XFAD mouse model of Alzheimer’s Disease
SJ Sukoff Rizzo1, SK Quinney2, KD Onos1, KJ Keezer1, DR Jones2, AR Masters2, IF Metzger2, JA Meyer2, J Peters2, SC Persohn2, BR McCarthy2, AA Riley2, M Sasner1, G Howell1, H Williams1, AJ Oblak2, BL Lamb2, and PR Territo2

MODEL-AD: Late-Onset Alzheimer’s Disease Models
Bruce Lamb on behalf of the MODEL-AD Consortium

MODEL-AD: Characterization of Familial AD Models (5xFAD, APP/PS1, hTau, 3xTg-AD)
Adrian Oblak on behalf of the MODEL-AD Consortium

Characterizing the APOE4/Trem2R47H Mouse Model for Late Onset Alzheimer’s Disease
Harriet Williams on behalf of the MODEL-AD Consortium

Screening of Common Spices Against Multi-Drug Resistant Mycobacterium tuberculosis
Swati Singh1, Arpita Batta1,2,  Maria Kulsoom1, T. N. Dhole2, B. N. Mishra1, Vineeta Singh1